Lee Hambright
Stock Analyst at Bernstein
(3.41)
# 970
Out of 5,090 analysts
27
Total ratings
75%
Success rate
10.63%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Market Perform | $172 → $193 | $201.93 | -4.42% | 5 | Oct 6, 2025 | |
| MDT Medtronic | Maintains: Outperform | $97 → $98 | $101.36 | -3.31% | 3 | Aug 20, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $138 → $144 | $125.08 | +15.13% | 5 | Apr 17, 2025 | |
| PODD Insulet | Initiates: Outperform | $300 | $304.49 | -1.47% | 1 | Nov 6, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Outperform | $42 | $20.92 | +100.76% | 1 | Nov 6, 2024 | |
| DXCM DexCom | Maintains: Outperform | $82 → $86 | $65.49 | +31.32% | 2 | Oct 25, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $92 → $100 | $97.52 | +2.54% | 1 | Oct 24, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $350 → $365 | $575.34 | -36.56% | 2 | May 31, 2023 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $136 → $152 | $94.28 | +61.22% | 1 | May 3, 2023 | |
| SYK Stryker | Upgrades: Outperform | $288 → $295 | $364.02 | -18.96% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $86.19 | +56.63% | 3 | Mar 16, 2022 |
Johnson & Johnson
Oct 6, 2025
Maintains: Market Perform
Price Target: $172 → $193
Current: $201.93
Upside: -4.42%
Medtronic
Aug 20, 2025
Maintains: Outperform
Price Target: $97 → $98
Current: $101.36
Upside: -3.31%
Abbott Laboratories
Apr 17, 2025
Maintains: Outperform
Price Target: $138 → $144
Current: $125.08
Upside: +15.13%
Insulet
Nov 6, 2024
Initiates: Outperform
Price Target: $300
Current: $304.49
Upside: -1.47%
Tandem Diabetes Care
Nov 6, 2024
Initiates: Outperform
Price Target: $42
Current: $20.92
Upside: +100.76%
DexCom
Oct 25, 2024
Maintains: Outperform
Price Target: $82 → $86
Current: $65.49
Upside: +31.32%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $97.52
Upside: +2.54%
Intuitive Surgical
May 31, 2023
Maintains: Outperform
Price Target: $350 → $365
Current: $575.34
Upside: -36.56%
Zimmer Biomet Holdings
May 3, 2023
Maintains: Market Perform
Price Target: $136 → $152
Current: $94.28
Upside: +61.22%
Stryker
Mar 16, 2022
Upgrades: Outperform
Price Target: $288 → $295
Current: $364.02
Upside: -18.96%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $86.19
Upside: +56.63%